EUVIMEDEUVIMED entdecken
Crossref

A CCR4 antagonist attenuates atopic dermatitis-like skin inflammation by inhibiting the recruitment and expansion of Th2 cells and Th17 cells

Masako Sato, Kazuhiko Matsuo, Yoko Susami, Ayaka Yamashita, Haruko Hayasaka, Yuta Hara, Keiji Nishiwaki, Naoki Oiso, Akira Kawada, Atsushi Otsuka, Takashi Nakayama

International Immunology · 2023

DOI: 10.1093/intimm/dxad019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, 2023. Verfasst von Masako Sato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Osaka-sayama, Osaka 589-8511, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Kindai University Fund for Antiaging Center Project, Lydia O’leary Memorial Pias Dermatological Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CCR4 is a major trafficking receptor for T-helper (Th) 2 cells and Th17 cells and is considered as a potential therapeutic target for atopic dermatitis (AD). The CCR4 ligands CCL17 and CCL22 have been reported to be upregulated in the skin lesions of AD patients. Of note, thymic stromal lymphopoietin (TSLP), a master regulator of the Th2 immune response, promotes the expression of CCL17 and CCL22 in AD skin lesions. Here, we investigated the role of CCR4 in an AD mouse model induced by MC903, a TSLP inducer. Topical application of MC903 to ear skin increased the expression of not only TSLP but also CCL17, CCL22, the Th2 cytokine IL-4, and the Th17 cytokine IL-17A. Consistently, MC903 induced AD-like skin lesions as shown by increased epidermal thickness; increased infiltration of eosinophils, mast cells, type 2 innate lymphoid cells, Th2 cells, and Th17 cells; and elevated serum levels of total IgE. We also found increased expansion of Th2 cells and Th17 cells in the regional lymph nodes (LNs) of AD mice. Compound 22, a CCR4 inhibitor, ameliorated AD-like skin lesions with reduction of Th2 cells and Th17 cells in the skin lesions and regional LNs. We further confirmed that compound 22 diminished the expansion of Th2 cells and Th17 cells in the coculture of CD11c+ dendritic cells (DCs) and CD4+ T cells derived from the regional LNs of AD mice. Collectively, CCR4 antagonists may exhibit anti-allergic effects by inhibiting both the recruitment and expansion of Th2 cells and Th17 cells in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicMiceAnimalsTh2 CellsTh17 CellsImmunity, InnateSkinCytokinesThymic Stromal LymphopoietinInflammation

Stichwörter der Autor:innen

CCL17CCL22CCR4MC903atopic dermatitis

Substanzen

CytokinesThymic Stromal Lymphopoietin

Autor:innen und Institutionen

  • Department of Dermatology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Osaka-sayama, Osaka 589-8511, Japan.
  • Division of Chemotherapy, Kindai University Faculty of Pharmacy, Kowakae 3-4-1, Higashi-Osaka, Osaka 577-8502, Japan.
  • Faculty of Science and Engineering, Department of Science, Graduate School of Science and Engineering, Kindai University, Kowakae 3-4-1, Higashi-Osaka, Osaka 577-8502, Japan.
  • Division of Computational Drug Design and Discovery, Kindai University Faculty of Pharmacy, Kowakae 3-4-1, Higashi-Osaka, Osaka 577-8502, Japan.
  • Department of Dermatology, Kindai University Nara Hospital, 1248-1 Otoda, Ikoma, Nara 630-0293, Japan.

Förderung

  • Kindai University Fund for Antiaging Center Project
  • Lydia O’leary Memorial Pias Dermatological Foundation

Zitieren

APA

Sato, M., Matsuo, K., Susami, Y., Yamashita, A., Hayasaka, H., Hara, Y., Nishiwaki, K., Oiso, N., Kawada, A., Otsuka, A., & Nakayama, T. (2023). A CCR4 antagonist attenuates atopic dermatitis-like skin inflammation by inhibiting the recruitment and expansion of Th2 cells and Th17 cells. International Immunology. https://doi.org/10.1093/intimm/dxad019

Vancouver

Sato M, Matsuo K, Susami Y, Yamashita A, Hayasaka H, Hara Y, et al. A CCR4 antagonist attenuates atopic dermatitis-like skin inflammation by inhibiting the recruitment and expansion of Th2 cells and Th17 cells. International Immunology. 2023. doi:10.1093/intimm/dxad019

BibTeX
@article{Sato2023,
  author = {Sato, Masako and Matsuo, Kazuhiko and Susami, Yoko and Yamashita, Ayaka and Hayasaka, Haruko and Hara, Yuta and Nishiwaki, Keiji and Oiso, Naoki and Kawada, Akira and Otsuka, Atsushi and Nakayama, Takashi},
  title = {A CCR4 antagonist attenuates atopic dermatitis-like skin inflammation by inhibiting the recruitment and expansion of Th2 cells and Th17 cells},
  journal = {International Immunology},
  year = {2023},
  doi = {10.1093/intimm/dxad019}
}
Kostenlos starten →